J. Peña-Sagredo

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials

R. Collins, C. Gordon, D. Isenberg, 2016, Arthritis & rheumatology.

Cancer in biopsy-proven giant cell arteritis. A population-based study.

Javier Martín, M. González-Gay, J. Llorca, 2007, Seminars in arthritis and rheumatism.

The erythrocyte sedimentation rate is associated with the development of visual complications in biopsy-proven giant cell arteritis.

Javier Martín, M. González-Gay, J. Llorca, 2008, Seminars in arthritis and rheumatism.

Generalized granuloma annulare and giant cell arteritis.

M. González-Gay, J. Val-Bernal, T. Vázquez-Rodríguez, 2008, Clinical and experimental rheumatology.

Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience.

M. González-Gay, M. Fariñas, M. Hernández, 2008, Clinical and experimental rheumatology.

Non-typhi Salmonella infection in patients with rheumatic diseases on TNF-alpha antagonist therapy.

L. Carmona, M. Rodríguez-Gómez, M. Gonzalez-gay, 2009, Clinical and experimental rheumatology.

Implication of the age in the clinical spectrum of giant cell arteritis.

M. González-Gay, C. González-Juanatey, J. Llorca, 2008, Clinical and experimental rheumatology.

Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis

J. Berciano, J. Miró, C. Leno, 1990, Annals of neurology.